Formerly known as Orchid Life, Medika Natura was established in 2006 by former university friends, Abdul Razak Mohd Isa and Mustadza Muhamad, who share a common passion for horticulture and botany. When they learned about the vast, untapped, scientific potential in biotechnology, they began exploring tissue culture technology in orchids, food crops and medicinal plants.
Their innovative work led to opportunities to meet and collaborate with public universities and research institutions to further the research and development in botanical drugs and high-value herbal ingredients, including plants that have been long used in traditional medicine such as Labisia pumila, known locally as Kacip Fatimah.
Left: Abdul Razak Mohd Isa, Right: Mustadza Muhamad
Board of Advisors/Board of Directors
Datuk Ali Abdul Kadir
Chairman of the Board of Advisors
Datuk Ali Kadir heads the Board of Advisors for Medika Natura. He is also an Independent Non-Executive Director of Ekuiti Nasional Berhad (Ekuinas) and Member of the Investment Committee. He is the Chairman of JcbNext Berhad and Enra Group Berhad; Board Member of Glomac Berhad, Citibank Berhad, Labuan Financial Services Authority, as well as other private companies and foundations.
From 1999 to 2004, Datuk Ali was Chairman of the Securities Commission of Malaysia, and also sat on a number of national and international committees, including the EXCO of International Organization of Securities Commission (IOSCO) as a member.
He is a Fellow of the Institute of Chartered Accountants in England and Wales (ICAEW), member of the Malaysian Institute of Certified Public Accountants (MICPA) and the Malaysian Institute of Accountants. He is also the current Honorary Advisor to ICAEW-KL City Chapter and Honorary Fellow of the Institute of Chartered Secretaries & Administrators (UK).
Advisor (North America)
Mike Dovbish is the Executive Director and a Founding Member of Nutrition Capital Network (NCN), an investor and partnering platform for growth companies in health and wellness, and provides strategic guidance and prepares participating companies for NCN Investor Conferences.
He also works with companies on their business plans and overall strategy to best position them for growth and investment, including identifying and introducing potential investors and strategic partners. Mike has worked with entrepreneurs on their business strategy, capital raising, market opportunity assessment, value proposition and partnership development. In response to the pandemic, in 2020, he led NCN in transforming in-person investor meetings into immersive digital events, and a hybrid event and community platform.
He received a Bachelor of Arts in Political Science from the University of California, Irvine and an MBA from Boston University, United States.
Mike has been mentoring and guiding Medika Natura on its entry strategies into the US market since 2017, as part of the company’s global expansion exercise.
Prof. Dr. Zhari Ismail
Prof. Zhari is an academic and professional in the pharmacy discipline who is experienced in setting standards for the halal industry.
Prof Zhari was among a team of leading researchers assembled by Medika Natura in 2011 to study plant and herb pharmacology at a tissue culture technology laboratory in Kulim Hi-Tech Park in Kedah, Malaysia.
Supported by the Kedah State Executive Council, Kulim Hi-Tech Park was set up by KBioCorp, a government-linked company (GLC) in partnership with Medika Natura, which was then known as Orchid Life. He was instrumental in uncovering the efficacy of Labisia pumila in curtailing obesity, and published his findings in a comparative study  in 2014. This served as the stepping stone for Medika Natura to commercialize Labisia pumila.
Prof Zhari is a Professor in Pharmaceutical Chemistry at Universiti Sains Malaysia where he has been a lecturer since 1982. To date, he has published more than 250 scientific articles at international, regional and national levels, and written several books and monographs including an Index of Malaysian Medicinal Plants. He has also received several international and national awards in herbal and related products.
Dato’ Amin Rafie Othman
Director of Corporate Affairs
Dato’ Amin graduated with a Degree in Economics and International Politics from University College of Wales, Aberystwyth, United Kingdom, and later pursued a Master of Business Administration (MBA) in Export Management and International Business from City University Business School, United Kingdom.
Dato’ Amin has served as the Independent Non-Executive Director of MYP Ltd, which is listed on the Singapore Stock Exchange. In a career spanning over 30 years, he has held various leadership positions including Executive Director of Smith Zain Securities Sdn. Bhd.; Senior General Manager and a Director of RHB Asset Management Sdn. Bhd.; and CEO of Maybank Investment Management Sdn. Bhd.
He was formerly the Deputy Chairman and Senior Independent Non-Executive Director of WZ Satu Berhad. He was also the past President of the Malaysian Association of Asset Managers and a member of the Listing Committee of Bursa Malaysia Securities Berhad.
In 2018, Dato’ Amin was inducted into the Board of Directors of Mudajaya Berhad. He also serves as Chairman of the Combined Nomination and Remuneration Committee, and Investment Committee.
Partners / Collaborators
- Ministry of Agriculture and Food Industries (MAFI)
- Ministry of International Trade and Industry (MITI)
- Institute for Medical Research, Malaysia (IMR)
- Forest Research Institute of Malaysia (FRIM)
- Universiti Kebangsaan Malaysia (UKM)
- Universiti Putra Malaysia (UPM)
- Universiti Sains Malaysia (USM)
- Malaysian Technology Development Corporation (MTDC)